Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
To Really Cut Health Spending, Put Pharmacists on the Front Line
Sixteen percent of all U.S. healthcare expenditures can be attributed to patients failing to properly adhere to their prescriptions. Pharmacists can be an important, and valuable, part of a patient’s care team.
Posted in -
Who Pays in Medicare Part D? Giving Plans More Skin in the Game
Private plans have the potential to lead the way toward innovative contracting approaches that emphasize value and, in doing so, deliver on the original vision for the Part D marketplace.
Posted in -
PODCAST: The Biggest Health Care Issues of the 2020 Election
In this episode of the Brookings Cafeteria podcast, health policy experts from the USC-Brookings Schaeffer Initiative discuss the presidential candidates’ health proposals, and also look at what to do about surprise medical billing.
Posted in -
The Success of Medicare Advantage Makes it a Better Policy Choice than ‘Medicare for All’
This public-private partnership is delivering high-quality health care at comparatively low cost.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Retroactive Enrollment: A Feasible Way to Bring Auto-Enrollment to the Individual Market
Helping people benefit from the programs for which they are eligible could have a significant impact on the share of Americans with health coverage, possibly making the idea of automatic enrollment into coverage attractive across the political spectrum.
-
Understanding the Bipartisan Senate Finance Prescription Drug Reform Package
“USC-Brookings Schaeffer Initiative experts unpack the bipartisan Senate Finance prescription drug reform package.
-
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
This study provides the first evidence to our knowledge that near-universal access to Medicare at age 65 is associated with improvements in population-level cancer mortality, and provides new evidence on the differences in the impact of health insurance by gender.
-
Considerations For Expanding International Reference Pricing Beyond Medicare Part B
Experts lay out considerations for expanding the administration’s proposed model beyond Medicare Part B drugs.
-
Longitudinal Analysis of Dementia Diagnosis and Specialty Care Among Racially Diverse Medicare Beneficiaries
The burden of Alzheimer’s disease and other dementias is rapidly growing. Researchers found vast majority of dementia patients don’t receive specialty diagnosis and care.
-
Using the Drug Pricing Netflix Model to Help States Tackle the Hep C Crisis
Researcher Neeraj Sood has explored innovative payment models as a strategy for government entities to be able to pay for lifesaving cures that could eradicate diseases like hepatitis C. Louisiana, with some input from Sood, has just implemented a modified version of a subscription model to pay for Hep C treatments.